WFH-Webinar: shared decision-making for hemophilia treatment
Die World Federation of Hemophilia (WFH) führt eine dreiteilige Webinar-Serie zum Thema Shared-Decision-Making durch:
"The three-part webinar series will cover the factor and non-factor treatments available for hemophilia, such as standard half-life (SHL), extended half-life (EHL), bispecific antibody, and rebalancing agent products, and gene therapy. We will cover how to consider the benefits and risks of each treatment, as well as the advantages of using SDM for people with hemophilia and for healthcare providers. The third webinar will share real-life experiences of physicians and PWH using the WFH SDM Tool. The presentations will be followed by an extensive Q&A period.
The three 90-minute sessions will take place on:
This webinar series is relevant for people with hemophilia, healthcare providers, and national member organization (NMO) members. Presentations will be given in English, with live interpretation offered in Spanish and French.